Literature DB >> 12854969

Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.

Xiaoqing Wu1, Thomas M McIntyre, Guy A Zimmerman, Stephen M Prescott, Diana M Stafforini.   

Abstract

Plasma platelet-activating factor acetylhydrolase (PAF-AH) is a phospholipase that inactivates platelet-activating factor (PAF) and PAF-like lipids to generate products with little or no biological activity. The levels of circulating PAF-AH correlate with several disease syndromes. We previously reported that mediators of inflammation regulate the expression of the human PAF-AH gene at the transcriptional level. In the present paper, we characterize the constitutive expression of plasma PAF-AH using the mouse gene as a model system, and we report comparative results obtained using human and mouse promoter constructs. We first cloned, sequenced and analysed the promoter region of the murine plasma PAF-AH (mPAF-AH) gene and found that this gene lacks a canonical TATA box. We demonstrated that the cis -elements required for basal transcription are localized within the -316 to -68 bp region. In vitro band-shift and supershift assays showed that Sp1 and Sp3 transcription factors from RAW264.7 and J774A.1 macrophage nuclear extracts bound strongly to a distal GC-rich site within -278/-243 [specificity protein (Sp-A)] and to a proximal TC-rich motif within -150/-114 (Sp-B). In addition, we observed weak binding to a GA-rich site within -110/-82 (Sp-C). The regions containing Sp-B and Sp-C are highly conserved between the human and mouse genes. Forced expression of Sp1 or Sp3 in Sp-lacking Drosophila SL2 cells induced markedly the activity of the exogenous mPAF-AH promoter in a dose-dependent manner, and this induction was dependent on the presence of intact Sp-A and Sp-B. Interestingly, we found that the Sp1- and Sp3-associated DNA-binding activities increased during the maturation of primary human monocytes into macrophages in cell culture. These results demonstrate that Sp1 and Sp3 are key factors that contribute to the basal, constitutive transcription of the plasma PAF-AH gene in macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854969      PMCID: PMC1223687          DOI: 10.1042/BJ20030636

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3.

Authors:  M Tone; M J Powell; Y Tone; S A Thompson; H Waldmann
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

2.  Identification and characterization of a transcriptional regulator for the lck proximal promoter.

Authors:  A Yamada; S Takaki; F Hayashi; K Georgopoulos; R M Perlmutter; K Takatsu
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

3.  GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis.

Authors:  C Fandos; M Sánchez-Feutrie; T Santalucía; F Viñals; J Cadefau; A Gumà; R Cussó; P Kaliman; J Canicio; M Palacín; A Zorzano
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

4.  The zinc finger repressor, ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Sp1.

Authors:  E Wieczorek; Z Lin; E B Perkins; D J Law; J L Merchant; Z E Zehner
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

5.  Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R Quarck; B De Geest; D Stengel; A Mertens; M Lox; G Theilmeier; C Michiels; M Raes; H Bult; D Collen; P Van Veldhoven; E Ninio; P Holvoet
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

6.  Developmental expression of Sp1 in the mouse.

Authors:  J D Saffer; S P Jackson; M B Annarella
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 7.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 8.  Platelet-activating factor acetylhydrolases in health and disease.

Authors:  L W Tjoelker; D M Stafforini
Journal:  Biochim Biophys Acta       Date:  2000-10-31

Review 9.  The expanding superfamily of phospholipase A(2) enzymes: classification and characterization.

Authors:  D A Six; E A Dennis
Journal:  Biochim Biophys Acta       Date:  2000-10-31

10.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

View more
  3 in total

1.  Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.

Authors:  Jane F Ferguson; Christine C Hinkle; Nehal N Mehta; Roshanak Bagheri; Stephanie L Derohannessian; Rhia Shah; Megan I Mucksavage; Jonathan P Bradfield; Hakon Hakonarson; Xuexia Wang; Stephen R Master; Daniel J Rader; Mingyao Li; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

Review 2.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

3.  DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque.

Authors:  Jingjin Li; Xiaoping Zhang; Mengxi Yang; Hang Yang; Ning Xu; Xueqiang Fan; Gang Liu; Xintong Jiang; Jiasai Fan; Lifang Zhang; Hu Zhang; Ying Zhou; Rui Li; Si Gao; Jiangli Jin; Zening Jin; Jingang Zheng; Qiang Tu; Jingyi Ren
Journal:  Clin Epigenetics       Date:  2021-08-21       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.